Company ProfilePremium

Ambica Agarbathies Aroma & Industries Limited

Company Profile Analysis

Tickers: AMBICAAGAR.NS, 532335.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Ambica Agarbathies Aroma & Industries Limited - Company showcase

Year Founded & Workforce

1946

Ambica Agarbathies Aroma & Industries Limited logo

Ambica Agarbathies Aroma & Industries Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Ambica Agarbathies Aroma & Industries Limited Overview

Ambica Agarbathies Aroma & Industries is an 80-year-old, family-controlled South Indian incense house that has been listed since its 1996 public issue. The family describes it as the first agarbatti company to list on Indian exchanges. Its core franchise is the green-branded "Ambica" range of herbal and masala incense, led by Durbar Bathi, a hand-rolled stick launched in the mid-1950s that uses natural resins and 63 herbs. The range also includes dhoop sticks, sambrani cups, camphor and allied pooja products. The brand is strongest in Andhra Pradesh, Telangana and Tamil Nadu. A capital-heavy hospitality arm sits alongside the incense business: the 84–90-room Ambica Empire hotel in Vadapalani, Chennai, and an operation in Visakhapatnam. In FY2026 this arm absorbed about half of total assets and most of the company's debt. Revenue was ₹141 crore in FY2026, but net profit was only ₹3.4 crore, interest cover is thin and the stock trades at about 0.37x book value. The equity story is therefore a debate about brand value versus balance-sheet drag.


Company's own description (Annual Report FY2025-26, MD&A)

The MD&A says the company manufactures and sells incense sticks in India and operates hotels in Chennai and Visakhapatnam. It also says the company is involved in film production and distribution. It describes the business as founded in 1946 and based in Eluru, West Godavari district, Andhra Pradesh. The MD&A states that incense counts for "more than 80% of the revenue in overall turnover". It names Durbar Bathi, Amrutham (Herbal Bathies) and Athisaya (spelled "Athjisaya") Dhoop as its major products. For the hotel division, the company says it caters to business travellers, tourists and event clientele through "a mix of luxury, mid-scale, and budget properties".

On markets, the MD&A says domestic incense sales split roughly 35% South India, 30% West, 18% North and 17% East. It says about 61% of domestic consumption is rural, and that "about 90 foreign countries are using our Agarbathies". That claim sits awkwardly with the same report's disclosure of NIL foreign exchange earnings for FY2026.

Independent characterisation

In economic terms Ambica is three businesses under one listed shell:

  1. A branded consumer-staples incense business (about 77% of FY2026 total income). This is a regional FMCG franchise with real brand equity in the Telugu states and Tamil Nadu. ICRA noted in 2018 that the Ambica brand is well established in Andhra Pradesh, Telangana and Tamil Nadu. The business is changing shape. In FY2026, purchases of stock-in-trade were ₹78.89 crore, or 56% of revenue from operations. Raw materials consumed were only ₹20.17 crore. In FY2025 the figures were ₹58.43 crore (47%) and ₹25.44 crore. Ambica is therefore increasingly a brand owner, sourcing and trading finished or semi-finished incense from third parties, rather than a vertically integrated hand-rolling manufacturer. This lowers capital intensity but compresses gross margin. Gross margin fell from 31.6% in FY2025 to 30.0% in FY2026.

  2. A single-asset hospitality business (about 23% of FY2026 total income). The core asset is Ambica Empire, a 3.5–4-star business and medical-tourism hotel in Vadapalani, Chennai. The family also cites Ambica Sea Green in Visakhapatnam, a 40-room property. The segment holds ₹124.14 crore of assets, which is 50.7% of the total. It carries ₹105.60 crore of segment liabilities, which is 80% of total liabilities. It reported a pre-tax segment loss of ₹1.08 crore in FY2026. Most of the company's interest burden sits here.

  3. Legacy and ancillary activities. These include film production and distribution, wind power generation, a farmland resort with club house and health centre, and real estate or construction. None of these is a reported segment. Their financial contribution is not separately disclosed.

Business and revenue model

DimensionCharacterisation
Revenue modelAbout 77% product sales (incense, dhoop, sambrani, camphor) and about 23% services (room nights, food & beverage, banqueting/MICE). No subscription or licensing income disclosed
Value-chain positionBrand owner and partial manufacturer in incense. Hand-rolled herbal lines are made in-house. Commodity lines are increasingly bought in. In hospitality, the company is owner-operator (no third-party brand management disclosed)
CustomersIncense: distributors and stockists, then general trade and kirana retail; also modern trade and e-commerce (BigBasket lists 17 SKUs). Hotel: corporate travellers, medical tourists (the hotel is near SIMS and Apollo hospitals), wedding and MICE clientele
End-marketsIndian household religious consumption (structural, low-cyclicality); Chennai urban hospitality (cyclical)
Go-to-marketDistributor network built since 1969 across AP and Telangana. Family claims pan-India presence and exports to Europe and Latin America through a separate export line (Sugandh India, Oct 2025)

Strategy

Stated strategy

ThemeCompany language / evidenceAnalyst assessment
Plough back profits; no dividendBoard does not recommend a dividend because profits "are planned to be ploughed back into the business operations" (Directors' Report FY2026)Consistent with negative FCF; no capital-return policy
Overseas expansion"The company plans to explore and tap overseas markets… new products… first launched in the domestic markets and then… overseas" (Annexure I FY2026)Aspirational; NIL forex earnings in FY2026
Scalable platforms and processesMD&A (HR section) refers to "building robust platforms and implementing scalable processes"Generic language, no quantified programme
Hospitality positioningMD&A expects FY2025-26 to be a year of "consolidation and strategic expansion" for hotel operators, driven by domestic leisure, spiritual tourism, MICE and weddingsNo company-specific capex or expansion plan disclosed
Herbal / traditional brand identityFamily emphasis on herbal products, green branding, hand-rolled quality and BIS certification of agarbattiCredible brand moat in the South
Promoter capital supportPreferential issue of ₹2.12 crore to promoter group for working capital (May–Aug 2026)Small relative to ₹88 crore debt; signals promoter commitment but not a balance-sheet fix

The company publishes no investor day, presentation or formal strategy document. Strategic themes are drawn from the Annual Report FY2026 and promoter statements.

Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)

DateInitiativeDetailStatus
FY2025–FY2026Shift toward traded / outsourced incenseStock-in-trade purchases rose from ₹58.43 crore (FY2025) to ₹78.89 crore (FY2026)Ongoing (inferred from financials)
30 May 2026Preferential equity raise8,48,600 shares; initially ₹24, revised to ₹25 per share; ₹2.12 crore; for working capital; 3-month utilisation windowApproved at EGM 30 Jun 2026; allotment approved 25 Aug 2026
2025–26Industry leadershipFamily member Ambica Ramanjaneyulu as AIAMA President; promoting BIS standards for agarbattiOngoing
Sep 2023 (outside window, relevant)Hotel renovationAmbica Empire complete renovationCompleted

Sustainability and ESG commitments

None disclosed. CSR under Section 135 is "not applicable". No BRSR is filed. No targets.

Cost programmes

None announced.

Medium-term financial targets / guidance

None. The company provides no revenue, margin or leverage guidance.

Products & Services

Agarbathies Division

Product / brandDescription & specificationsTarget customerLaunchIndicative price / packSource
Ambica Durbar Bathi (flagship)Green, hand-rolled herbal masala stick made with natural resins and 63 herbs; marketed as "homam in a stick"; long-burningDevotional households, South India corec.1953–55₹75 / 125 g; ₹145 / 220 gAnnual Report FY2026; Sugandh India; BigBasket
Ambica Javaji BathiThe company's first brand; javaji (civet-type) fragranceTraditional devotional1,946—Sugandh India
Amrutham (Herbal Bathies)Herbal incense range in multiple fragrances, natural base materialsHerbal / premium devotional——Annual Report FY2026
Athisaya Dhoop (Dhoop Cups / Dhoop Sticks)Dhoop cups and dhoop sticks; very high review volume onlineMass devotional—₹90 / 12 cups; ₹22 / 65 g sticksAnnual Report FY2026; BigBasket
Ambica Baba Aarti / Baba Harathi Flora BattiHerbal flora battiDevotional—₹105 / 175 gSugandh India; BigBasket
Ambica Gow Pooja (Panchagavya)Natural herbal stick made with panchagavya (cow-derived ingredients)Traditional / ritual users—₹58 / 70 gSugandh India; BigBasket
Ambica BangaramHerbal agarbatti brandDevotional——Sugandh India
Ambica HeavenPremium fragrance stickUrban / premium—₹80 / 48 g; ₹145 / 90 gSugandh India; BigBasket
Nitya Pooja (Sandal; 6-in-1)Daily-use pooja sticks, multi-fragrance packMass daily-use—₹62 / 85 g; ₹65 / 132 gBigBasket
100% LuckkEveryday fragrance stickMass—₹52 / 70 gBigBasket
Lakshmi TulasiBasil-leaf-based natural stickDevotional—₹80 / 100 gBigBasket
Dhoop SambraniSambrani (benzoin) dhoopMass South India1,992—Sugandh India
Cup Sambrani / Colour Cup SambraniSelf-burning sambrani cupsMass, pan-India1,996—Sugandh India
Pure Camphor (tablets, block)Pooja camphorDevotional households—₹275 / 150 g tablets; ₹180 / 100 g blockBigBasket
Kum Kum PowderNatural kumkumDevotional—₹35 / 100 gBigBasket
Scented agarbattisFragrance variants including gulab, strawberry, spicy, sandal, rosemary, rose, oriental, opium, myrrh, lavender and jasmineMass and urbanIntroduced after 1986—Wright Research profile; Sugandh India
Export product lineSeparate line for European and Latin American marketsOverseas distributors——Sugandh India

The family states that Ambica has about 200–300 products and 20–25 herbal agarbatti brands (Sugandh India, Oct 2025). The SKUs and brands below are confirmed from company filings, retail listings and the promoter interview. Retail prices are BigBasket list prices as observed online (2025–26) and are indicative only. The company does not disclose pricing.

Hotel Division

Property / offeringSpecificationsTarget customerLatest refurbishmentPricingSource
Ambica Empire, Vadapalani, Chennai3.5-star on OTAs; the family calls it four-star. Room count varies by source: 84 (event-venue listing), 86 (OTAs), about 90 (family). Five suites; 7 floors; built 1999. Near Vadapalani Metro, SIMS Hospital and Vadapalani Murugan Temple; about 30–33 min from Chennai airportBusiness travellers, medical tourists, pilgrims, eventsComplete renovation completed Sep 2023Dynamic OTA pricing; ADR not disclosed. OTA guest scores 5.6–6.0/10Hotels.com / Expedia / Travelocity; SuccessfulMeetings; Wright Research
— Banqueting / MICE4 meeting rooms (His Highness about 1,800 sq ft, Her Majesty, Citrus Hall, 16 A.D.); about 3,900 sq ft event space; capacity about 460Weddings, corporate MICE——SuccessfulMeetings
— F&BRestaurants: Royal Palate, Green Chillies, Andhra Samskruti; pubIn-house and walk-in——Wright Research
— WellnessFull-service Ayurvedic spa, steam room, gymLeisure / medical guests——OTA listings
Ambica Sea Green, VisakhapatnamAbout 40 rooms (family statement). The MD&A says the company operates hotels in Chennai and Visakhapatnam. Whether the listed company owns this property, or a family entity does, is not confirmedLeisure / business——Sugandh India; Annual Report FY2026 MD&A

Other (non-segment) activities

ActivityDetailFinancial disclosure
Film production & distributionUpstox's profile says the company produced three feature films and distributed over 500 films. The family says it made "seven to eight movies"—
Wind power generationReferenced in Screener's key points and in the Annual Report FY2026 MD&A risk section—
Farmland resortClub house and health centre on owned farmland—
Real estate / constructionTradomate reports a commercial development partnership with APSRTC in Vizag. not found in filings reviewed—

Financial Narrative

FY2022–FY2024: Screener standalone data, rounded to ₹1 crore (PAT and EPS derived from Screener/TipRanks EPS). FY2025–FY2026: company audited results (30 May 2026), converted from ₹ lakh. Blank cells mean not available at comparable granularity in the sources reviewed.

Margins and growth

Revenue CAGR. FY2022–FY2026 (four years): about 5.0%. Screener: 5-year sales CAGR 0%, 3-year 6%, 10-year 3%. Sales peaked at ₹168 crore in FY2020 and FY2026 remains about 16% below that peak.

Commentary. Three features dominate.

Volatile top line: Revenue fell from ₹168 crore (FY2020) to ₹98 crore (FY2024). The causes were COVID disruption to the hotel, the agarbatti industry's shift to imported-stick-free and machine-made supply, and a contraction in trading volumes. It then recovered 44% over two years to ₹141 crore, largely through traded goods.

No operating leverage: EBITDA excluding other income has stayed around ₹10 crore in FY2025 and FY2026 despite revenue growth of 14%, because the incremental revenue was low-margin trading.

Earnings depend on other income: Other income exceeded PBT in every year from FY2022 to FY2026 except FY2024 (when PBT was negative). Without other income, the company would have reported pre-tax losses in FY2025 (–₹2.62 crore) and FY2026 (–₹3.43 crore). FY2026 other income of ₹8.46 crore includes ₹6.88 crore of interest income (cash flow statement). This links to the ₹67.31 crore of "other current financial assets", which appear to be interest-bearing loans or advances.

Finance cost burden: At ₹11.27 crore, finance costs consume 111% of EBITDA excluding other income.

Quarterly trend (INR Cr, Screener standalone)

Q1 FY2027 (June 2026) sales fell 18% YoY to ₹24.65 crore. OPM expanded to 12.8%, the best since Q1 FY2025's 15.3%, and net profit was flat YoY at ₹1.11 crore. TTM sales stand at about ₹136 crore and TTM PAT at about ₹3.42 crore (Screener).

Balance sheet

Commentary. Total borrowings excluding lease rose 18% in FY2026, from ₹75.03 crore to ₹88.45 crore, and are up about 50% on the Screener basis since FY2023. The increase funded a ₹9.45 crore rise in receivables and an ₹11.69 crore rise in other current financial assets, not productive capex (FY2026 capex was only ₹0.71 crore). Cash fell to ₹0.28 crore. Equity is inflated by the FY2018 revaluation reserve (reserves rose by about ₹48 crore that year), so the 0.37x P/B partly reflects a market discount to revalued hotel property rather than a pure margin of safety. Goodwill is nil. There are no business-combination intangibles.

Cash flow

FY2025–FY2026 from the company cash flow statement (30 May 2026 filing). The parsed figures are partially garbled in the PDF; CFO and FCF reconcile to Screener's –₹7 crore and ₹1 crore and –₹7 crore FCF. FY2022–FY2024 from Screener.

Commentary. Cash conversion has collapsed. CFO/EBITDA fell from over 90% in FY2022–FY2024 to 14% in FY2025 and –66% in FY2026. FY2026 working-capital outflows were large: receivables –₹9.45 crore and other current assets –₹12.49 crore. FY2026 investing cash flow was positive only because ₹6.88 crore of interest income is classified there. The company is borrowing to fund working capital and advances while earning interest on those advances. The quality of these advances is the single most important open question for equity holders.

Ratios

ROIC (NOPAT ÷ (equity + net debt)). FY2026: EBIT excluding other income of ₹7.84 crore less tax at 25% gives NOPAT of ₹5.88 crore, against invested capital of ₹200.90 crore, so ROIC ≈ 2.9%. FY2025: NOPAT ₹6.20 crore ÷ ₹182.76 crore gives ≈ 3.4%. ROIC is well below any plausible cost of capital (about 12–14% for an Indian nano-cap), so the company is destroying economic value on a reported basis.

Ratio commentary. Leverage is moderate on book D/E (0.85x) but heavy on cash-earnings measures (net debt/EBITDA excluding OI of about 8.7x). Interest coverage has not exceeded 1.5x in any of the last five years. Working-capital days have more than doubled from FY2020's 72 days. Debtor days jumped from 42 to 61 in FY2026. Screener flags low interest coverage and rising debtor days.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2024FY2025FY2026

Agarbathies segment revenue incl. allocated other income (INR Cr)

—96.59115.84

Hotel segment revenue incl. allocated other income (INR Cr)

—32.3333.70

Total segment revenue = total income (INR Cr)

103128.92149.54

Agarbathies segment result, profit before tax (INR Cr)

—2.726.11

Hotel segment result, profit before tax (INR Cr)

—-0.03-1.08

Agarbathies segment margin (%)

—2.85.3

Hotel segment margin (%)

—-0.1-3.2

Agarbathies share of total income (%)

—74.977.5

Hotel share of total income (%)

—25.122.5

Agarbathies segment assets (INR Cr)

—99.15120.71

Hotel segment assets (INR Cr)

—124.39124.14

Agarbathies segment liabilities (INR Cr)

—16.3426.53

Hotel segment liabilities (INR Cr)

—97.92105.60

Revenue by Segment

MetricQ4 FY2025Q3 FY2026Q4 FY2026

Agarbathies segment revenue (INR Cr)

23.5746.6117.33

Hotel segment revenue (INR Cr)

8.818.618.33

Agarbathies segment PBT (INR Cr)

-1.640.972.15

Hotel segment PBT (INR Cr)

1.08-0.07-0.78

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

11611798123.62141.08

Other income (INR Cr)

1555.318.46

Total income (INR Cr)

117122103128.92149.54

Cost of goods sold: materials + purchases + inventory change (INR Cr)

———84.5198.73

Gross profit (INR Cr)

———39.1142.35

Employee benefit expense (INR Cr)

———7.559.44

Admin & other manufacturing expenses (INR Cr)

———21.3122.74

EBITDA excl. other income (INR Cr)

148510.2510.17

EBITDA incl. other income (INR Cr)

15131015.5618.63

Depreciation & amortisation (INR Cr)

3221.992.33

Operating income, EBIT excl. other income (INR Cr)

11638.267.84

Finance costs (INR Cr)

1291110.8611.27

Profit before tax (INR Cr)

13-22.695.03

Tax expense (INR Cr)

———2.201.58

Net profit (INR Cr)

2.402.53-3.660.493.45

Other comprehensive income (INR Cr)

———7.510.00

Total comprehensive income (INR Cr)

———8.003.45

EPS basic, on PAT (INR)

1.401.47-2.130.292.01

EPS diluted, on PAT (INR)

1.401.47-2.130.292.01

Dividend per share (INR)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

———31.630.0

EBITDA margin excl. other income (%)

12.16.85.18.37.2

Operating (EBIT) margin excl. other income (%)

9.55.13.16.75.6

Net margin (%)

2.12.2-3.70.42.4

Revenue YoY growth (%)

-18.90.9-16.226.114.1

Other income as % of PBT

100167—197168

Income Statement and Margin Analysis (%)

MetricQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027

Sales (INR Cr)

33.5136.0531.0530.1434.6354.0422.2724.65

Operating profit (INR Cr)

3.092.351.273.091.833.281.973.16

OPM (%)

9.226.524.0910.255.286.078.8512.82

Other income (INR Cr)

1.421.511.331.742.141.193.391.98

Interest (INR Cr)

2.842.932.442.722.323.073.163.00

PBT (INR Cr)

1.250.51-0.571.521.240.901.371.47

Net profit (INR Cr)

0.930.38-1.941.140.930.560.821.11

EPS (INR)

0.540.22-1.130.660.540.330.480.65

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

219204211223.53244.85

Property, plant & equipment (INR Cr)

———122.81121.43

Right-of-use assets (INR Cr)

———6.916.53

Fixed assets incl. ROU, Screener basis (INR Cr)

122122120130128

Non-current investments (INR Cr)

8899.5811.67

Inventories (INR Cr)

———5.145.29

Trade receivables (INR Cr)

———14.1623.61

Other current financial assets (INR Cr)

———55.6267.31

Cash & cash equivalents (INR Cr)

———1.550.28

Long-term borrowings (INR Cr)

———59.7768.28

Short-term borrowings (INR Cr)

———15.2620.17

Total borrowings excl. lease (INR Cr)

———75.0388.45

Lease liabilities (INR Cr)

———7.187.36

Borrowings incl. lease, Screener basis (INR Cr)

6463678296

Net debt excl. lease (INR Cr)

———73.4888.17

Deferred tax liability, net (INR Cr)

———16.3017.18

Total equity (INR Cr)

102105101109.28112.73

Goodwill & intangibles (INR Cr)

———0.010.00

Current assets (INR Cr)

———79.99100.82

Current liabilities (INR Cr)

———29.7038.41

Working capital (INR Cr)

———50.2962.41

Book value per share (INR)

59.461.158.863.665.6

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

16851.42-6.92

Capital expenditure (INR Cr)

0238.790.71

Free cash flow (INR Cr)

1662-7.37-7.63

Investing cash flow (INR Cr)

0-22-4.626.30

Financing cash flow (INR Cr)

-17-7-63.33-0.65

Interest paid (INR Cr)

———11.5512.01

Dividends paid (INR Cr)

00000

Share buybacks (INR Cr)

00000

Net change in cash (INR Cr)

-1000.12-1.27

CFO / EBITDA, Screener (%)

1121019114-66

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE on closing equity (%)

2.42.4-3.60.43.1

ROA on closing assets (%)

1.11.2-1.70.21.4

ROCE, Screener (%)

77578

Current ratio (x)

———2.692.62

Debt/equity, borrowings incl. lease (x)

0.630.600.660.750.85

Debt/equity, borrowings excl. lease (x)

———0.690.78

Net debt / EBITDA incl. other income (x)

———4.724.73

Net debt / EBITDA excl. other income (x)

———7.178.67

Interest coverage, EBIT incl. OI / interest (x)

1.081.330.821.251.45

Asset turnover, revenue / closing assets (x)

0.530.570.460.550.58

Debtor days (days)

9160354261

Inventory days (days)

5710302220

Payable days (days)

10817711518

Cash conversion cycle (days)

4053-64963

Working capital days (days)

111162197144161

Revenue by Region and Region Margins & Growth (%)

MetricFY2024FY2025FY2026

Domestic (India) revenue from operations (INR Cr)

98123.62141.08

Export revenue (INR Cr)

——0

Domestic revenue YoY growth (%)

-16.226.114.1

Segment Overview

SegmentAndhra Pradesh / TelanganaTamil NaduRest of IndiaOverseas

Agarbathies

Core heartland: factory at Eluru, distribution network since 1969, brand leadership claimed in South India

Strong (ICRA 2018)

Presence claimed pan-India; not quantified

NIL reported in FY2026 filings. Family claims Europe and Latin America line, possibly via a group entity or merchant exporters

Hotel

Visakhapatnam property (ownership unconfirmed)

Ambica Empire, Chennai (primary asset)

——

Capital Markets

Metric1-Year3-Year5-Year

Share price CAGR, Screener as of 19 Oct 2026 (%)

-4-135

Annualised returns, Kotak Neo as of 13 May 2026 (%)

-14.8-2.09-6.99

Value by Reference Point

Reference pointValueDateSource

All-time high

₹44.40

28 Jan 2022

TradingView

All-time low

₹5.70

25 Feb 2009

TradingView

52-week high / low

₹29.9 / ₹20.0

As of 19 Oct 2026

Screener

Recent price

₹25.2

19 Oct 2026

Screener

Earlier sample prices

₹29.59 (26 Apr 2024); ₹28.57 (5 Nov 2024); ₹23.89 (13 May 2026); ₹24.80 (6 Aug 2026); ₹23.83 (5 Oct 2026)

—

Equitymaster; 5paisa; Kotak Neo; Torus; IncredMoney

Beta / volatility

Beta 1.32; daily volatility about 2.96% (TradingView); volatility about 5.27x Nifty (ICICIdirect)

—

TradingView; ICICIdirect

Valuation Snapshot

MetricValueBasis

Market cap (INR Cr)

43.3 (old share count); about 45.4 (post-allotment)

Screener; derived

Enterprise value (INR Cr)

about 131.5

Market cap 43.3 + debt 88.45 – cash 0.28 (FY2026); excludes lease liabilities

P/E, TTM (x)

12.7

Screener (TTM EPS about ₹2.00)

P/B (x)

0.37–0.38

BV ₹65.6 per share

EV/EBITDA incl. other income (x)

about 7.1

FY2026 EBITDA ₹18.63 crore

EV/EBITDA excl. other income (x)

about 12.9

FY2026 EBITDA ₹10.17 crore

EV/Sales (x)

about 0.97

TTM sales about ₹136 crore

Dividend yield (%)

0.00—

Share Price & Returns

DateInstrumentSharesPrice (INR)Amount (INR Cr)Allottees

Aug 2026

Preferential equity

848,600252.12

Four promoter-group members

Credit Ratings

AgencyRatingOutlookDateStatus

ICRA

[ICRA]B on ₹66 crore term loan

Stable

24 Oct 2018

Withdrawn 16 Nov 2018

Moody's / S&P / Fitch

———

Not rated

Current

———

Annual Report FY2026 states credit rating obtained during the year: "NA"

Bucket Details

BucketAmount (INR Cr)Note

Current borrowings (within 12 months, incl. current maturities)

20.17

Balance sheet FY2026

Non-current borrowings

68.28

Balance sheet FY2026

Lease liabilities (non-current)

7.36

Balance sheet FY2026

Longest known maturity

May 2033

ICRA 2018: term loan March 2018 – May 2033

Analyst Conclusions

Management guidance

None quantified. Qualitatively, management expects improving hospitality demand from domestic leisure, spiritual tourism, MICE and weddings, and intends to explore overseas markets and reinvest profits (Annual Report FY2026).

Consensus growth expectations

None (no coverage). Run-rate indicators: TTM sales about ₹136 crore and TTM PAT about ₹3.42 crore. Q1 FY2027 sales fell 18% YoY, but OPM was 12.8%.

Bull case

  1. Deep asset discount with an identifiable catalyst. The stock trades at about 0.37x book (₹65.6 BV vs about ₹25 price), with an owned 84–90-room hotel in a prime Chennai metro-connected location. Any monetisation, lease-out or management contract that retires part of the ₹105.6 crore of hotel-segment liabilities could re-rate the equity sharply. Removing the hotel's interest burden alone could more than double PBT, since FY2026 finance costs were ₹11.27 crore.

  2. The incense franchise is improving. The agarbathi segment result rose 125% to ₹6.11 crore in FY2026, and Q1 FY2027 OPM reached 12.8%. Herbal heritage brands fit the premium segment's roughly 30% growth, and BIS formalisation favours branded players.

  3. Promoter alignment is increasing. Promoters bought new shares at ₹25 (above the current price), lifted their stake to 46.08% and have no pledges. This signals confidence and reduces the risk of a dilutive outside raise.

Bear case

  1. No core operating profit after interest. Excluding ₹8.46 crore of other income (mostly ₹6.88 crore of interest), FY2026 shows a pre-tax loss of about ₹3.4 crore. ROIC is about 3%. If the ₹67 crore of advances generating that interest are impaired or related-party in nature, earnings and book value are overstated.

  2. Cash burn and rising leverage. CFO was –₹6.92 crore and FCF –₹7.63 crore in FY2026. Debt rose 18% to ₹88.45 crore and cash fell to ₹0.28 crore. Interest cover is 1.45x. The ₹2.12 crore promoter infusion covers about two months of interest.

  3. Structural disadvantages. The company has about 1% of a fragmented market dominated in marketing by ITC and Cycle Pure. Its growth is increasingly low-margin trading (gross margin down to 30.0%). R&D is zero and exports reportedly nil. Governance carries key-person risk: a CMD over 75, an all-family executive team, unpaid IDs and error-prone disclosures.

Key catalysts and monitorables (next 12 months)

#Catalyst / monitorableExpected timingWhat to watch
1Q2 FY2027 resultsNov 2026 (trading window closed from 1 Oct 2026)Festive-season agarbathi sales, whether 12%+ OPM holds, hotel segment P&L
2Use of the ₹2.12 crore preferential proceedsWithin 3 months of allotment (by about Nov 2026)Utilisation disclosure; receivable reduction
3Composition of ₹67.31 crore other current financial assetsH1 FY2027 balance sheet (Nov 2026) and FY2027 Annual ReportCounterparties, related-party share, interest yield, recoverability
4Debt trajectoryHalf-year balance sheetWhether borrowings stabilise below ₹90 crore
5Hotel strategyAny Reg 30 disclosureAsset sale, lease, brand tie-up, or further capex
6Q3 FY2027 comparison vs the ₹54 crore Q3 FY2026 spikeFeb 2027Tough base; risk of optically weak YoY revenue
7Succession planningOngoingBoard changes; elevation of third-generation family members
8Export disclosureFY2027 Annual ReportAny forex earnings
9Contingent liabilities and RPT disclosuresFY2027 Annual ReportUpdated amounts and AOC-2 details
10LiquidityOngoingDaily volumes; promoter creeping acquisitions

Concluding analyst verdict

Ambica Agarbathies Aroma & Industries is a heritage regional consumer brand tied to a capital-hungry, under-earning hotel. The listed equity reflects the combined result. On the positive side, the Ambica incense franchise is real. Durbar Bathi has sold for about 70 years, the brand is recognised in Andhra Pradesh, Telangana and Tamil Nadu, and the agarbathi segment's pre-tax result more than doubled in FY2026 to ₹6.1 crore. Promoters have stepped up with fresh equity at ₹25, pledged nothing, and own 46%. With the stock at about 0.37x a book value underpinned by an owned Chennai hotel, the theoretical asset-value case is easy to make.

The cash-flow and capital-allocation evidence argues the other way. Consolidated operating earnings do not cover interest: excluding other income, FY2026 was loss-making before tax. Free cash flow has been negative for two years, and borrowings rose to ₹88 crore while cash fell to under ₹0.3 crore. Reported profit depends on interest earned on ₹67 crore of other current financial assets whose counterparties are not disclosed. That single line item, equal to 60% of equity, could determine whether book value is a floor or an illusion. Revenue growth has come mainly from low-margin traded goods. Innovation and R&D are nil, and national competitors outspend the company by orders of magnitude. Governance is family-centred, with an over-75 CMD reappointed to 2029, unpaid independent directors and recurring disclosure errors.

In the meantime, they should demand clarity on the advances book. Absent a catalyst that separates the incense brand from the hotel balance sheet, a low ROIC of about 3% is likely to keep the valuation discount in place. Upgrade triggers would be disclosure and recovery of the advances, debt below ₹70 crore, or a hotel transaction.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleDINTenureBackground / educationAgeShares held (31 Mar 2026)FY2026 remuneration (INR)

Ambica Krishna

Chairman & Managing Director (KMP)

00,391,898

Since incorporation (1995); reappointed for 13 Feb 2026 – 12 Feb 2029

Second-generation promoter; more than four decades in production, purchase and marketing; joined the family business 1967–68

Over 75

13,91,806

12,00,000 (salary). Approved going forward: ₹24,00,000 p.a. (₹2,00,000/month) as minimum remuneration

Ambica Ramachandra Rao

Whole-time Director (KMP)

01,678,538

Since 30 Nov 2001; retires by rotation, reappointed at the 31st AGM

Undergraduate; more than two decades in purchase and marketing of agarbathies

55 (born 26 Feb 1971)

6,16,950

Nil

Satyavathi Perla

Whole-time Director (woman director)

07,141,289

Reappointed at 29th AGM (Sep 2024)

Promoter-family member

—

1,39,989

12,00,000

Mallikarjunarao Voleti

Independent Director; chairs Audit, NRC and Stakeholders' Relationship Committees

————0

Nil (no sitting fees paid)

B V Subrahmanyeswarao

Independent Director

————0

Nil

Chunduru Anjaneya Swamy

Independent Director

08,810,748

Reappointed at 30th AGM (26 Sep 2025)

——0

Nil

Alapati (Ambica) Hanuma

Chief Financial Officer

——

Promoter-group family member (listed as promoter group in 2019 SAST filing)

———

Uma Gayathri

Company Secretary & Compliance Officer

——————

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

26 Sep 2025

Chunduru Anjaneya Swamy reappointed as Independent Director

Second term

12 Feb 2026

Ambica Krishna reappointed CMD for three years from 13 Feb 2026

Ratified at 31st AGM, 29 Sep 2026

29 Sep 2026

Ambica Ramachandra Rao reappointed on retirement by rotation

Routine

Shareholding Trend

Holder categoryMar 2023Mar 2024Mar 2025Mar 2026Sep 2026

Promoters & promoter group (%)

48.3543.6943.4143.4146.08

FIIs (%)

0.000.030.000.000.00

DIIs / mutual funds (%)

0.000.000.000.000.00

Public / retail (%)

51.6656.2956.5856.5853.91

Number of shareholders

9,1168,6808,8308,3358,351

Competitive Landscape

Key Competitors

#CompetitorOwnerScale (latest public)Positioning vs AmbicaSource
1

Cycle Pure Agarbathies

NR Group (Mysuru)

Group turnover about ₹1,700 crore; about ₹1,000 crore of agarbatti; 75 countries (date of figures not specified)

National leader by value; about 20% of the organised segment; heavy fragrance R&D and marketing

YourStory; Social Samosa (Oct 2025)

2

Mangaldeep

ITC Ltd

Agarbatti revenue not separately disclosed; ITC says Mangaldeep is No. 1 by volume and No. 2 by value

Deep distribution, top ad spender, premium sub-brand "Prana"

exchange4media (Sep 2025)

3

Zed Black

Mysore Deep Perfumery House

₹650 crore turnover (FY2021)

Strong in economy segment and North/Central India

YourStory

4

Hari Darshan

Hari Darshan Sevashram

About ₹300 crore annual production value

Strong in wet dhoop

YourStory

5

Moksh

Moksh Agarbatti Co

—

National organised player

ResearchAndMarkets

6

Forest (incl. Baahubali sambrani cups)

Private

—

Strong in Telangana and AP sambrani cups, overlapping directly with Ambica's home market

Sugandh India (Telangana interview)

7

Darshan

Private

—

Popular in Telangana

Sugandh India

8

GT (Tamil Nadu sambrani cups)

Private

—

Competes in sambrani cups in Tamil Nadu

Sugandh India

9

Cycle "Naivedya" (sambrani cups)

NR Group

Included in #1

Competes with Ambica Cup Sambrani

Sugandh India

10

Shri Balaji, Big Bell (Kaccha Bela), Amrutha, Lakshmi

Private

—

Regional economy brands

Sugandh India

11

Unorganised / local rollers

—

About 30–40% of the market (Social Samosa); the top six hold only about 40% (ITC)

Price competition

Social Samosa; exchange4media

“—” = not publicly disclosed.

Peer Comparison FY2026

MetricAmbica Agarbathies (FY2026)NR Group / Cycle PureITC MangaldeepMDPH / Zed Black

Incense revenue (INR Cr)

about 116 (segment, incl. allocated other income)

about 1000 (agarbatti)

—

650 (FY2021, total)

Total revenue (INR Cr)

141

about 1700

ITC group (far larger)

650

Revenue growth (%)

14.1———

EBITDA margin (%)

7.2 excl. OI

———

R&D intensity (%)

0

Not disclosed (fragrance R&D emphasised)

——

Geographic reach

South India core; NIL reported exports

75 countries

National; exports

National

“—” = not publicly disclosed.

Recent Developments

The Annual Report states there were no significant or material orders by regulators or courts and no capital-market penalties in the last three years.

Company Snapshot

$16.3M

Revenue

1946

Founded

West Godavari District, India

Headquarters

SWOT Analysis

Strengths

  • Heritage brand with longevity. Durbar Bathi has been in continuous production since about 1953–55 and remains a top-reviewed SKU (1,600+ ratings on BigBasket). The family says the business is about 80 years old (Sugandh India, Oct 2025).
  • Regional brand equity validated by a third party. ICRA (Oct 2018) described the Ambica brand as reputed in AP, Telangana and Tamil Nadu.
  • Revenue recovery. Revenue from operations rose 44% from ₹98 crore (FY2024) to ₹141.08 crore (FY2026).
  • Incense segment profitability improving. The agarbathi segment result more than doubled from ₹2.72 crore to ₹6.11 crore in FY2026, with segment margin rising from 2.8% to 5.3%.
  • Promoter commitment. Promoters infused ₹2.12 crore at ₹25 per share (Aug 2026), raised their stake to 46.08%, and have no pledged shares (FY2026 disclosure).
  • Hard-asset backing. Book value of ₹65.6 per share against a share price of about ₹25 (P/B about 0.37x). PPE is ₹121.43 crore, including an owned Chennai hotel in a dense urban location.
  • Clean audit and compliance record. The FY2026 audit opinion is unmodified. There have been no SEBI or exchange penalties in three years, no fraud reported under s.143(12), and no investor complaints in FY2026.

Weaknesses

  • Earnings depend on other income. FY2026 PBT of ₹5.03 crore against other income of ₹8.46 crore implies a pre-tax operating loss of ₹3.43 crore excluding other income.
  • Thin interest coverage. EBIT including other income covered interest only 1.45x in FY2026 and has stayed between 0.82x and 1.45x across FY2022–FY2026.
  • Negative free cash flow. FCF was –₹7.37 crore in FY2025 and –₹7.63 crore in FY2026. CFO/EBITDA was –66% in FY2026.
  • Loss-making hotel absorbs capital. The hotel holds 50.7% of assets and 80% of liabilities but posted a ₹1.08 crore segment loss in FY2026.
  • Value destruction. ROIC is about 3% and ROE averaged 0% over three years (Screener).
  • Zero R&D and weak disclosure quality. R&D is NIL (Annexure I FY2026). The Annual Report contains repeated MD&A errors and EPS is calculated inconsistently.
  • Rising working-capital intensity. Debtor days rose from 42 to 61. Receivables grew 67% to ₹23.61 crore and other current financial assets rose 21% to ₹67.31 crore.

Opportunities

  • Formalisation and BIS standards. BIS certification for agarbatti, championed by AIAMA under a family member's presidency, could shift share from unorganised players (Sugandh India, Oct 2025).
  • Premium and herbal demand. The premium incense segment is growing at about 30% (Telangana distributor, Sugandh India). Ambica's herbal portfolio is naturally positioned.
  • E-commerce and quick-commerce reach. 17 SKUs are already listed on BigBasket. D2C could expand reach beyond the South at low cost.
  • Export monetisation. The company states it plans to tap overseas markets, against a reported base of NIL in FY2026. India's agarbatti exports are estimated at about ₹1,000–1,200 crore per year.
  • Hotel asset monetisation. A sale, lease or management contract for Ambica Empire could deleverage the ₹105.6 crore of hotel-segment liabilities and unlock the P/B discount.
  • Religious and medical tourism in Chennai. These support RevPAR for a hotel located near major hospitals and a prominent temple (OTA listings).

Threats

  • National-brand competition. ITC Mangaldeep (No. 1 by volume) and Cycle Pure (about 20% of the organised market) are pushing into South India.
  • Interest-rate and refinancing risk. ₹88.45 crore of borrowings, a ₹66 crore term loan running to May 2033 (ICRA 2018), and no current credit rating.
  • Key-person and succession risk. The CMD is over 75 and has been reappointed to February 2029 with no disclosed succession plan.
  • Counterparty risk on advances. ₹67.31 crore of other current financial assets (60% of equity) has undisclosed counterparties.
  • Hotel disruption. Management itself cites OTA-led alternative accommodation as a risk (MD&A FY2026). OTA guest scores of 5.6–6.0/10 limit pricing power.
  • Liquidity and minority-holder risk. Daily volumes are often below 2,000 shares (MarketsMojo: about 1.12k on 18 Jun 2026). There is zero institutional ownership and a share base concentrated among promoters.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
28 May 2025Board approves FY2025 audited results: revenue ₹123.62 crore, PAT ₹0.49 crore, OCI ₹7.51 crore. Q4 FY2025 net loss ₹1.94 crore, driven by ₹1.71 crore deferred taxFY2025 headline profit depressed by tax; EPS reported as ₹4.66 on a TCI basis
29 Jul 2025Board and NRC meetingGovernance / remuneration matters
13 Aug 2025Q1 FY2026 results: sales ₹30.14 crore, PAT ₹1.14 crore (+1.8% YoY), EPS ₹0.66Steady start
2 Sep 2025Board meeting approves AGM notice and related mattersRoutine
26 Sep 202530th AGM at Eluru; ID Chunduru Anjaneya Swamy reappointed (special resolution)Board continuity
29 Oct 2025Sugandh India publishes in-depth promoter-family interview (history, products, hotels, exports, AIAMA presidency)Rare public disclosure on strategy and heritage
6–8 Nov 2025AIAMA Expo, Bengaluru, under the presidency of Ambica RamanjaneyuluIndustry visibility
10 Nov 2025Q2 FY2026 results: sales ₹34.63 crore, PAT ₹0.93 crore (flat YoY)Margin compression (OPM 5.3% vs 9.2%)
21 Jan 2026Reg 74(5) certificate for Q3; no demat requestsRoutine
6 Feb 2026Intimation of board meeting for Q3 resultsRoutine
12 Feb 2026Q3 FY2026 results: record sales ₹54.04 crore, PAT ₹0.56 crore. CMD Ambica Krishna reappointed for three years. Independent directors' separate meeting heldRevenue spike from trading purchases (₹40.19 crore); CMD succession deferred
13 Feb 2026New CMD term commences (to 12 Feb 2029)Leadership continuity, aged over 75
31 Mar 2026FY2026 year-end: debt ₹88.45 crore (+18%), cash ₹0.28 crore, receivables ₹23.61 crore (+67%)Balance-sheet stretch
Apr–Jun 2026Annual disclosure: no promoter shares encumbered in FY2026Positive governance signal
25 May 2026Notice of board meeting to approve FY2026 results and consider preferential fund-raisingSignals capital need
30 May 2026FY2026 results: revenue ₹141.08 crore (+14.1%), PBT ₹5.03 crore (+87%), PAT ₹3.45 crore (vs ₹0.49 crore). Unmodified audit opinion. Preferential issue of up to 8,48,600 shares at ₹24 approved; EGM called for 30 Jun 2026Earnings recovery; promoter equity infusion
1 Jun 2026Clarification: issue price revised to ₹25 (premium ₹15); size about ₹2.12 crorePrice set at SEBI ICDR floor / market
6 Jun 2026EGM notice published; remote e-voting 27–29 Jun 2026Process
30 Jun 2026EGM approves preferential issue; funds to be used within 3 months for working capitalShareholder approval
5 Aug 2026Intimation of board meeting to review Q1 FY2027 resultsRoutine
7 Aug 2026Board meeting for Q1 results deferredMinor reporting-timeliness concern
Aug 2026Q1 FY2027 results: sales ₹24.65 crore (–18% YoY), OPM 12.8%, PAT ₹1.11 crore (flat YoY)Margin up, revenue down; exact filing date not confirmed
25 Aug 2026Board approves allotment of 8,48,600 preferential shares (₹2,12,15,000); AGM notice datedEquity base expands about 4.9%
4 Sep 202631st Annual Report (FY2025-26) filed with NSE and BSEPrimary disclosure
Sep 2026 (quarter end)Promoter holding rises to 46.08% from 43.41%Promoter consolidation
26 Sep 2026Trading window closed from 1 Oct 2026 until 48 hours after Q2 FY2027 resultsRoutine; Q2 results imminent
29 Sep 202631st AGM at Eluru: all three resolutions passed (adoption of accounts, Ramachandra Rao reappointment, CMD reappointment special resolution); scrutiniser's report filedGovernance continuity
15 Oct 2026Reg 74(5) compliance certificate for quarter ended 30 Sep 2026Routine

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue from operations rose from INR 1,160 Mn in FY2022 to INR 1,410.8 Mn in FY2026.
Ambica Agarbathies Aroma & Industries Limited — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations1,1601,1709801,236.21,410.8
Cost of goods sold: materials + purchases + inventory change———845.1987.3
Gross profit———391.1423.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Annual Report FY2025-26 (31st), filed 4 Sep 2026: — Corporate information, board, governance, MD&A, segments, R&D, forex, remuneration, shareholding distribution (nsearchives.nseindia.com)
  2. FY2026 Audited Results, Balance Sheet, Cash Flow, Segment Report and preferential issue outcome (30 May 2026): — FY2025–FY2026 financials, segment data, preferential issue terms (nsearchives.nseindia.com)
  3. Directors' Report FY2026 (IIFL mirror): — Financial results summary; cross-check (indiainfoline.com)
  4. Screener.in standalone: — FY2015–FY2026 P&L, balance sheet, cash flow, ratios, quarterly data, shareholding, announcements, market data (screener.in)
  5. Screener.in consolidated page: — Announcement log (May–Jun 2026); contingent liability flag (screener.in)
  6. ScanX news (Jun 2026): and — EGM, preferential issue at ₹25, allottees, non-encumbrance: scanx.trade · scanx.trade
  7. IncredMoney: — News log (Aug–Sep 2026); subsidiary reference (contradicted) (incredmoney.com)
  8. ICRA rationales: and — 2018 rating and withdrawal; ₹66 crore term loan: icra.in · icra.in
  9. Sugandh India interview (Oct 2025): — History, products, hotels, exports, AIAMA, welfare practices (sugandhindia.in)
  10. NSE SAST filing (Apr 2019): — Promoter group composition (nsearchives.nseindia.com)
  11. TradingView: — All-time high/low, beta, dividend history (tradingview.com)
  12. TipRanks: — Historical net income / EPS cross-check (tipranks.com)
  13. Kotak Neo, Torus Digital, Upstox, ICICIdirect, 5paisa, Equitymaster — Share price history and returns
  14. MarketsMojo: — Company profile, incorporation date, liquidity (marketsmojo.motilaloswal.com)
  15. Wright Research: — Factory locations, hotel facilities (wrightresearch.in)
  16. Tradomate: — APSRTC / subsidiary claims (tradomate.one)
  17. Hotel listings (Expedia, Travelocity, Hotels.com, Kayak, SuccessfulMeetings, Sembo) — Ambica Empire specifications
  18. BigBasket brand page: — SKU catalogue and indicative prices (bigbasket.com)
  19. The Week (Jul 2025): — ₹8,000 crore market size (theweek.in)
  20. exchange4media (Sep 2025): — ITC position; ₹12,000 crore estimate; top-six share (exchange4media.com)
  21. Social Samosa (Oct 2025): — ₹10,000 crore estimate; Cycle share (socialsamosa.com)
  22. YourStory: — Competitor scale (yourstory.com)
  23. Sugandh India (Telangana market): — Regional market and competitors (sugandhindia.in)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.